2 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
Follow NF1: new trials by email Literature Review of NF1 trials Research Report on NF1
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase II Trial of Poly-ICLC for Low-Grade Gliomas Poly ICLC - NF1, Low-grade Glioma | Phase 2 | Terminated | University of Alabama at Birmingham | 3 | 2022-02-08 | 2025-03-21 |
| Study of Sutent®/Sunitinib (SU11248) in Subjects With NF-1 Plexiform Neurofibromas Sutent®/Sunitinib - Neurofibromatosis, NF1 | Phase 2 | Terminated | Indiana University | 19 | 2012-03-01 | 2018-03-14 |
Neurofibroma, Plexiform (1) · Neurofibromatoses (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Heredodegenerative Disorders, Nervous System (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Nerve Tissue (1) · Neoplastic Syndromes, Hereditary (1) · Nerve Sheath Neoplasms (1) · Nervous System Diseases (1) · Nervous System Neoplasms (1) · Neurocutaneous Syndromes (1) · Neurodegenerative Diseases (1) · Neurofibroma (1) · Neuromuscular Diseases (1) · Peripheral Nervous System Diseases (1)
poly ICLC (1)
Indiana University (1) · University of Alabama at Birmingham (1)
United States (2)